Clinical implications of molecular heterogeneity in triple negative breast cancer.

Lehmann BD, Pietenpol JA
Breast. 2015 24 Suppl 2: S36-40

PMID: 26253813 · PMCID: PMC4641762 · DOI:10.1016/j.breast.2015.07.009

MeSH Terms (10)

Antineoplastic Agents Female Genetic Heterogeneity Humans Molecular Targeted Therapy Mutation Patient Selection Phenotype Transcription, Genetic Triple Negative Breast Neoplasms

Connections (2)

This publication is referenced by other Labnodes entities:

Links